FDA pushes need for plasma donations, with Mayo Clinic giving registry support

May 27  

Via Healthcare IT News

“The registry also supports collection of antibodies, critical to enabling research into which patients may be most at risk from the disease, he said.”

“To date, Mayo’s Covid program has been live since April and has treated 12,000 patients. An Institutional Review Board registers hospitals, doctors and patients and uses collected data to track outcomes.”

“The goal, according to Joyner, is to constantly be asking, ‘Are we safe?’ So far, safety data is looking good, he said. ‘Now, the question is, has the work we’ve done made a difference? So far, it’s too soon to tell.'”

“Since January of 2020, FDA has been concerned with the medical-product supply chain and the need to avoid disruptions, which compelled the agency to get in touch with more than 180 makers of human drugs and evaluate their entire supply chain, according to FDA Commissioner Dr. Stephen Hahn.”

MAA COVID-19 INFORMATION DISCLAIMER:

The Medical Alley Association is providing COVID-19 related information, including the “COVID-19 Resource Connect” feature on its website and summaries of laws, executive orders, and government programs that may be of interest to members, as a public service.   The Medical Alley Association makes no representations, guarantees, or warranties as to the accuracy, completeness, currency, or suitability of the COVID-19 related information provided by the Medical Alley Association on its website, in newsletters, or in any other communications. The Medical Alley Association specifically disclaims any and all liability for any claims or damages that may result from providing COVID-19 related information online or in other communications or linking to third party websites or other sources of information. The Medical Alley Association makes no effort to independently verify, and does not exert editorial control over, information provided by third parties.  

The Medical Alley Association does not endorse any of the products, vendors, consultants, or documentation referenced in, or connected to parties through, the COVID-19 Resource Connect feature or via email or other communications.

>
Success message!
Warning message!
Error message!